Slim Weight Loss Clinic in Homewood, Alabama, operates as a telehealth-focused medical weight loss practice led by a board-certified physician holding MD and FACS credentials. The clinic specializes exclusively in pharmacological approaches to chronic weight management and obesity treatment, with particular emphasis on GLP-1 receptor agonist therapies for patients throughout Alabama who require medical intervention for weight-related health conditions. By concentrating clinical expertise on evidence-based peptide therapies rather than offering a broad wellness menu, the practice delivers targeted treatment protocols for patients with elevated BMI, metabolic syndrome, and weight-related comorbidities including type 2 diabetes.
The clinic's treatment portfolio centers on three FDA-approved GLP-1 and dual-incretin receptor agonists: liraglutide, semaglutide, and tirzepatide. Liraglutide serves as the foundation therapy for patients new to GLP-1 treatment or those requiring a gradual dose escalation approach, while semaglutide provides once-weekly administration for patients seeking simplified dosing schedules with demonstrated cardiovascular benefits. Tirzepatide, the clinic's dual GIP/GLP-1 receptor agonist option, addresses patients who may benefit from enhanced glycemic control and weight reduction through combined incretin pathway activation. Each medication selection follows individualized assessment of patient medical history, current metabolic markers, weight loss goals, and tolerance considerations. The practice structures treatment protocols around established clinical guidelines for obesity medicine, with dosing adjustments based on patient response and side effect profiles rather than standardized timelines.
The lead provider's FACS certification indicates advanced surgical training, bringing a comprehensive understanding of obesity's physiological mechanisms and the anatomical considerations relevant to patients with significant weight-related health complications. This surgical background informs the clinic's approach to identifying patients who require pharmacological intervention versus those who might benefit from alternative or combined treatment modalities. Medical consultations address not only medication management but also the metabolic adaptations that occur during weight loss, helping patients understand the biological basis for appetite regulation, energy expenditure changes, and the role of incretin hormones in glucose homeostasis. The practice emphasizes diabetes management as an integrated component of weight loss treatment, recognizing that many patients present with both conditions requiring coordinated therapeutic approaches.
Patients access Slim Weight Loss Clinic entirely through telehealth consultations, eliminating geographic barriers for Alabama residents in suburban and rural areas who lack convenient access to specialized obesity medicine providers. Initial consultations involve comprehensive review of medical history, current medications, previous weight loss attempts, laboratory values, and specific health goals to determine appropriate GLP-1 therapy candidacy. Follow-up appointments monitor treatment tolerance, dose escalation schedules, weight trends, and metabolic parameter improvements including hemoglobin A1c for diabetic patients. The clinic coordinates with a pharmacy partner to fulfill prescriptions, streamlining the medication access process and ensuring patients receive pharmaceutical-grade peptide formulations with proper handling and storage instructions. This partnership model addresses common patient frustrations with medication availability and insurance navigation that often complicate weight loss treatment adherence.
What distinguishes this Homewood practice from general telemedicine weight loss services is its physician-led model with surgical credentials, ensuring medical oversight by a provider trained to recognize complex obesity presentations and contraindications that require specialized evaluation. The clinic does not offer nutritional counseling, fitness programming, or lifestyle coaching as standalone services, instead focusing clinical resources on pharmacological expertise and medical monitoring. This concentrated approach serves patients who have previously attempted behavioral modification without sufficient results and now require medication intervention, as well as those with obesity-related health conditions where weight reduction carries significant medical benefit. For Alabama patients seeking GLP-1 therapy through a telehealth platform with direct physician involvement rather than nurse practitioner-only models, Slim Weight Loss Clinic provides accessible specialist-level care for chronic weight management and metabolic health optimization.
Slim Weight Loss Clinic· MD, FACS
Dr. Gary T. Marshall, MD, FACS
Physician
Dr. Gary T. Marshall, MD, FACS practices in the New York City area and specializes in general surgery and critical care medicine
Dr. Gary Kawesch, MD, FACS
Physician
Dr. Gary Kawesch, MD, FACS practices in the Los Angeles area graduated with the highest Summa Cum Laude and Phi Beta Kappa honors from Yale University
Dr. Thierry Jacquemin, MD
Physician
Dr. Thierry Jacquemin is an international board-certified physician in Internal Medicine, and he has spent the last decade of his professional life helping his patients live better, smarter, longer, and prettier
Semaglutide Weight Management
GLP-1 receptor agonist injection for weight loss, administered once weekly
Tirzepatide Weight Management
Dual GLP-1 and GIP receptor agonist injection for weight loss
Liraglutide Weight Management
GLP-1 receptor agonist injection for weight loss (Saxenda)
Metformin Weight Management
Oral medication tablets for weight loss and blood sugar management
MyPeptideMatch.com is an independent directory. We do not provide medical advice. Always consult a qualified healthcare provider before starting any peptide therapy.
MyPeptideMatch